Manulife (Manufacturers Life Insurance)’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.61M Buy
638,047
+1,317
+0.2% +$18.9K 0.01% 994
2025
Q4
$9.84M Buy
636,730
+588
+0.1% +$10.8K 0.01% 881
2025
Q3
$13.8M Sell
636,142
-3,120
-0.5% -$69.6K 0.01% 739
2025
Q2
$14.2M Buy
639,262
+595,977
+1,377% +$13.2M 0.01% 704
2025
Q1
$1.03M Sell
43,285
-617
-1% -$14.6K ﹤0.01% 1800
2024
Q4
$929K Sell
43,902
-699
-2% -$18.3K ﹤0.01% 1941
2024
Q3
$1.44M Sell
44,601
-37,391
-46% -$1.1M ﹤0.01% 1726
2024
Q2
$1.95M Sell
81,992
-19,528
-19% -$501K ﹤0.01% 1504
2024
Q1
$3.03M Buy
101,520
+5,253
+5% +$164K ﹤0.01% 1368
2023
Q4
$3.08M Sell
96,267
-20,978
-18% -$609K ﹤0.01% 1335
2023
Q3
$3.43M Buy
117,245
+19,994
+21% +$719K ﹤0.01% 1270
2023
Q2
$4.38M Buy
97,251
+26,974
+38% +$1.03M ﹤0.01% 1152
2023
Q1
$2.42M Buy
70,277
+15,241
+28% +$495K ﹤0.01% 1350
2022
Q4
$1.52M Buy
55,036
+1,082
+2% +$28.7K ﹤0.01% 1461
2022
Q3
$1.32M Sell
53,954
-3,566
-6% -$114K ﹤0.01% 1495
2022
Q2
$1.71M Buy
57,520
+4,717
+9% +$206K ﹤0.01% 1454
2022
Q1
$2.92M Buy
52,803
+35,238
+201% +$1.74M ﹤0.01% 1406
2021
Q4
$937 Buy
17,565
+502
+3% +$23.3K ﹤0.01% 1874
2021
Q3
$722K Sell
17,063
-1,320
-7% -$67.4K ﹤0.01% 2034
2021
Q2
$1.23M Buy
18,383
+3,180
+21% +$173K ﹤0.01% 1871
2021
Q1
$673K Buy
15,203
+826
+6% +$30.7K ﹤0.01% 2109
2020
Q4
$417K Buy
14,377
+352
+3% +$8.76K ﹤0.01% 2315
2020
Q3
$307K Sell
14,025
-449
-3% -$7.98K ﹤0.01% 2280
2020
Q2
$163K Sell
14,474
-2,027
-12% -$22.2K ﹤0.01% 2586
2020
Q1
$108K Buy
16,501
+569
+4% +$8.11K ﹤0.01% 2562
2019
Q4
$249K Sell
15,932
-1,800
-10% -$20.4K ﹤0.01% 2449
2019
Q3
$131K Hold
17,732
﹤0.01% 2753
2019
Q2
$144K Buy
+17,732
New +$177K ﹤0.01% 2790
2018
Q3
Sell
-15,635
Closed -$233K 3740
2018
Q2
$233K Sell
15,635
-120
-0.8% -$2.01K ﹤0.01% 3013
2018
Q1
$271K Sell
15,755
-518
-3% -$8.07K ﹤0.01% 2785
2017
Q4
$197K Sell
16,273
-240
-1% -$2.29K ﹤0.01% 3012
2017
Q3
$170K Buy
16,513
+596
+4% +$8.52K ﹤0.01% 3103
2017
Q2
$362K Buy
15,917
+7
+0% +$144 ﹤0.01% 2533
2017
Q1
$311K Buy
15,910
+1,847
+13% +$35.9K ﹤0.01% 2518
2016
Q4
$222K Buy
14,063
+438
+3% +$7.28K ﹤0.01% 2701
2016
Q3
$276K Buy
13,625
+252
+2% +$4.63K ﹤0.01% 2531
2016
Q2
$239K Buy
13,373
+2,833
+27% +$42.2K ﹤0.01% 2580
2016
Q1
$148K Buy
+10,540
New +$163K ﹤0.01% 2818

Other funds holding SGRY

Manulife (Manufacturers Life Insurance)'s SGRY Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Surgery Partners (SGRY) stake by 0.21% in Q1 2026, buying an estimated $18.9K and bringing the position to 638,047 shares worth $7.61M. The position accounts for 0.01% of the portfolio, ranked #994.

Manulife (Manufacturers Life Insurance) first reported a position in SGRY in Q1 2016 and has held it in 38 quarters since. The position peaked at $14.2M in Q2 2025. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 638,047 shares of Surgery Partners worth $7.61M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 1,317 Surgery Partners shares in Q1 2026, an estimated $18.9K.
  • Surgery Partners made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #994 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Surgery Partners in Q1 2016 and has held it in 38 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Surgery Partners position peaked at $14.2M in Q2 2025.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.